3-[7-(5-chlorothiophen-2-yl)-1H-imidazo[4,5-b]pyridin-2-yl]-5-pyridin-4-yl-1H-pyrazolo[4,3-b]pyridine
C21H12ClN7S — CID 137042509
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[7-(5-chlorothiophen-2-yl)-1H-imidazo[4,5-b]pyridin-2-yl]-5-pyridin-4-yl-1H-pyrazolo[4,3-b]pyridine
3-[7-(5-chlorothiophen-2-yl)-1H-imidazo[4,5-b]pyridin-2-yl]-5-pyridin-4-yl-1H-pyrazolo[4,3-b]pyridine (PubChem CID 137042509) has the molecular formula C21H12ClN7S and a molecular weight of 429.90 g/mol. Its IUPAC name is 3-[7-(5-chlorothiophen-2-yl)-1H-imidazo[4,5-b]pyridin-2-yl]-5-pyridin-4-yl-1H-pyrazolo[4,3-b]pyridine.
Molecular Properties
| Compound Name | 3-[7-(5-chlorothiophen-2-yl)-1H-imidazo[4,5-b]pyridin-2-yl]-5-pyridin-4-yl-1H-pyrazolo[4,3-b]pyridine |
|---|---|
| PubChem CID | 137042509 |
| Molecular Formula | C21H12ClN7S |
| Molecular Weight | 429.90 g/mol |
| Exact Mass | 429.06 |
| IUPAC Name | 3-[7-(5-chlorothiophen-2-yl)-1H-imidazo[4,5-b]pyridin-2-yl]-5-pyridin-4-yl-1H-pyrazolo[4,3-b]pyridine |
| SMILES | Clc1ccc(-c2ccnc3nc(-c4n[nH]c5ccc(-c6ccncc6)nc45)[nH]c23)s1 |
| InChI | InChI=1S/C21H12ClN7S/c22-16-4-3-15(30-16)12-7-10-24-20-17(12)26-21(27-20)19-18-14(28-29-19)2-1-13(25-18)11-5-8-23-9-6-11/h1-10H,(H,28,29)(H,24,26,27) |
| InChIKey | LAQZYSQVVUEPMS-UHFFFAOYSA-N |
| XLogP | 5.34 |
| TPSA | 96.03 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 429.90 |
| LogP ≤ 5 | 5.34 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 137042509 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.